StockData
Jaguar Health, Inc. logo

Jaguar Health, Inc. (JAGX) stock

JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.39−0.03 (-7.14%)

Close on Nov 16, 2026Market cap $2.02MP/E –Yield –

Jaguar Health total assets

Total assets on the balance sheet at the end of each period.

Jaguar Health's total assets was $34.19M at Jun 30, 2026. For fiscal 2025 it was $38.32M, down 28.3% from the year before. Over ten years it grew 11.9% a year on average. The highest annual figure on record is $53.43M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$38.32M-28.3%
FY2024Dec 31, 2024$53.43M+5.2%
FY2023Dec 31, 2023$50.76M+7.0%
FY2022Dec 31, 2022$47.45M-10.9%
FY2021Dec 31, 2021$53.27M+24.3%
FY2020Dec 31, 2020$42.84M+17.7%
FY2019Dec 31, 2019$36.41M-11.3%
FY2018Dec 31, 2018$41.04M-5.9%
FY2017Dec 31, 2017$43.63M+1124.5%
FY2016Dec 31, 2016$3.56M-71.3%
FY2015Dec 31, 2015$12.41M+180.7%
FY2014Dec 31, 2014$4.42M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$34.19M-29.2%
Q1 FY2026Mar 31, 2026$37.43M-27.3%
Q4 FY2025Dec 31, 2025$38.32M-28.3%
Q3 FY2025Sep 30, 2025$49.47M-15.4%
Q2 FY2025Jun 30, 2025$48.27M-21.5%
Q1 FY2025Mar 31, 2025$51.46M-7.1%
Q4 FY2024Dec 31, 2024$53.43M+5.2%
Q3 FY2024Sep 30, 2024$58.47M+28.8%
Q2 FY2024Jun 30, 2024$61.46M+17.8%
Q1 FY2024Mar 31, 2024$55.39M-2.7%
Q4 FY2023Dec 31, 2023$50.76M+7.0%
Q3 FY2023Sep 30, 2023$45.38M-11.5%
Q2 FY2023Jun 30, 2023$52.17M+4.6%
Q1 FY2023Mar 31, 2023$56.93M+7.6%
Q4 FY2022Dec 31, 2022$47.45M-10.9%
Q3 FY2022Sep 30, 2022$51.29M-13.4%
Q2 FY2022Jun 30, 2022$49.89M-28.3%
Q1 FY2022Mar 31, 2022$52.91M-23.0%
Q4 FY2021Dec 31, 2021$53.27M+24.3%
Q3 FY2021Sep 30, 2021$59.26M+63.5%
Q2 FY2021Jun 30, 2021$69.54M+85.0%
Q1 FY2021Mar 31, 2021$68.71M+106.5%
Q4 FY2020Dec 31, 2020$42.84M+17.7%
Q3 FY2020Sep 30, 2020$36.23M+1.7%
Q2 FY2020Jun 30, 2020$37.58M+4.2%
Q1 FY2020Mar 31, 2020$33.28M-18.2%
Q4 FY2019Dec 31, 2019$36.41M-11.3%
Q3 FY2019Sep 30, 2019$35.63M-22.8%
Q2 FY2019Jun 30, 2019$36.07M-21.9%
Q1 FY2019Mar 31, 2019$40.66M-6.8%
Q4 FY2018Dec 31, 2018$41.04M-31.6%
Q3 FY2018Sep 30, 2018$46.12M+833.9%
Q2 FY2018Jun 30, 2018$46.16M+1191.2%
Q4 FY2017Dec 31, 2017$43.63M+1124.5%
Q3 FY2017Sep 30, 2017$59.99M+1075.9%
Q2 FY2017Jun 30, 2017$4.94M-31.4%
Q1 FY2017Mar 31, 2017$3.57M–
Q4 FY2016Dec 31, 2016$3.56M–
Q3 FY2016Sep 30, 2016$5.10M–
Q2 FY2016Jun 30, 2016$7.20M–

More Jaguar Health figures

See a number that looks wrong?